The Snf1 protein kinase family is widely conserved in eukaryotes and has been implicated in cellular responses to nutritional and environmental stresses. In the yeast Saccharomyces cerevisiae, the Snf1 (Cat1, Ccr1) serine/threonine kinase is essential for the response to glucose starvation and its activity is regulated by the glucose signal (41) . Snf1 is required for the transcription of genes involved in alternate-carbon-source utilization, respiration, and gluconeogenesis and also plays roles in sporulation, glycogen storage, thermotolerance, and peroxisome biogenesis (5, 35, 37, 39) .
The mammalian homolog, AMP-activated protein kinase (AMPK) (1, 3, 14, 28) , is involved in cellular stress responses (8, 21) and regulates HMG-CoA reductase and acetyl-CoA carboxylase (20) . Snf1 also inactivates yeast acetyl-CoA carboxylase, suggesting that the regulatory role in lipid metabolism is conserved (28, 41) . Additional common targets seem likely since AMPK and Snf1 have similar substrate recognition motifs (9) , but there is as yet no evidence implicating AMPK in transcriptional control.
Snf1 homologs have also been cloned from various plants (2, 17, 25, 29) , and some of the plant kinases provide Snf1 function in yeast (2, 29) . Other related protein kinases include PAR-1 of C. elegans (16) , mouse Msk (33) , and human p78, a protein implicated in pancreatic carcinoma (19) .
In yeast cells, the Snf1 kinase is complexed with other proteins, including the activating subunit Snf4 (Cat3) (6, 36) and the Sip1, Sip2, and Gal83 proteins (44, 45) . These components of the Snf1 kinase complex also have counterparts in higher eukaryotes (38, 40) . The Snf4 protein activates the Snf1 kinase in vivo and in vitro (4, 6, 36, 41) , and during glucose starvation Snf1 kinase activity increases in a Snf4-dependent manner (41) . In the two-hybrid system, the interaction between Snf1 and Snf4 is regulated by glucose: high glucose levels inhibit interaction and glucose limitation induces interaction (23) . Genetic and biochemical evidence indicates that when glucose is limiting, Snf4 binds to the Snf1 regulatory domain and counteracts an autoinhibitory interaction between the Snf1 kinase domain and the regulatory domain (23) .
Data indicating a regulated interaction between Snf1 and Snf4 in the two-hybrid system, however, is apparently contrary to coimmunoprecipitation and copurification data which suggests that Snf1 and Snf4 remain associated in cells grown in glucose (6, 11, 28, 45) . A possible explanation is that previous biochemical experiments were not quantitative, and perhaps the two-hybrid results reflect the behavior of a fraction of the Snf1 and Snf4 proteins which are not associated in glucosegrown cells. In this report, we provide evidence that most, if not all, of the Snf4 protein in a cell extract is associated with Snf1 when glucose levels are high. A second possibility is that another protein(s) interacts with both Snf1 and Snf4, thereby anchoring them into a complex, within which their interaction varies in response to glucose. In this scenario, the two-hybrid system detects only direct interaction, which occurs in response to glucose starvation, but not indirect interaction bridged by the other protein(s).
The other known components of Snf1 kinase complexes, Sip1, Sip2, and Gal83, are candidates for the proposed bridging protein(s). Sip1, Sip2, and Gal83 constitute a family of related proteins. Sip1 and Sip2 were identified in a two-hybrid screen for proteins that interact with Snf1 and by other genetic approaches (30, 44, 45) , and Gal83 was identified genetically by its effects on glucose regulation of GAL gene expression (10, 27) . All three proteins interact with Snf1 in glucose-grown cells, as determined by assays using the two-hybrid system and by coimmunoprecipitation from cell extracts (45) . A conserved C-terminal region of about 80 amino acids, designated the ASC domain, was shown to be sufficient for interaction with the Snf1 complex (45) . In immune complex assays of Snf1 kinase activity, Sip1, Sip2, and Gal83 are phosphorylated; moreover, mutation of GAL83 nearly abolishes Snf1 activity in such assays. Genetic evidence suggests that Sip1, Sip2, and Gal83 are alternate members of the kinase complex, possibly serving as adaptors that mediate the interactions of Snf1 with specific targets (10, 44, 45) . However, in vivo these proteins do not appear essential for function of the Snf1 pathway, as a sip1⌬ sip2⌬ gal83⌬ triple deletion mutant does not exhibit defects associated with the Snf Ϫ phenotype (10, 45) . No other mutant phenotypes were detected in the single or triple mutants (26, 45) .
Here, we address the roles of Sip1, Sip2, and Gal83 in the Snf1 kinase complex. We show that the fraction of Snf4 that is complexed with Snf1 is reduced in a sip1 sip2 gal83 triple mutant. Using the two-hybrid system, we show that Sip1, Sip2, and Gal83 interact independently with both Snf1 and Snf4. The ASC domain interacts directly with Snf4, and an internal region, conserved in all three proteins, interacts with the Snf1 regulatory domain (Snf1RD). These findings support the view that the Sip1/Sip2/Gal83 family of proteins anchors Snf1 and Snf4 into a complex. (34) and are listed in Table 1 . pRJ69 was constructed by PCR with an NPK5 clone (29) as template. pRJ324 and pRJ325 were made by PCR with genomic DNA from strains YM3033 and MCY2649, respectively, as templates. Plasmid pSH18-18 (gift from R. Brent) was used to transform strains to provide a lexAop-lacZ reporter. Standard genetic methods were followed, and yeast cells were grown in yeast extract-peptone (YEP) or selective synthetic complete (SC) medium containing 2% glucose (31) , except where noted.
MATERIALS AND METHODS

Strains
␤-Galactosidase assay. Filter lift assays for blue color were performed as described previously (44) . Transformants (6 to 8) were patched onto selective SC medium containing 2% glucose and grown for one day at 30ЊC; during this time cells in the patch become limited for glucose. Two-hybrid filter lift assays were then carried out and developed overnight. Since ␤-galactosidase is stable, twohybrid interactions that occur in medium with either a high or low level of glucose are detected. For quantitative assays, transformants were grown to midlog phase in selective SC medium containing 2% glucose, and ␤-galactosidase activity was assayed in permeabilized cells and expressed in Miller units (31) .
In vitro binding assay. Protein expression and in vitro binding assays were performed as described previously (22) . Snf4 and the Snf1 regulatory domain were cloned into pGEX3X (Pharmacia) as glutathione S-transferase (GST) fusions (pRJ31 and pRJ206, respectively). The ASC Sip2 and Sip2⌬ASC domains were cloned into pET-32a(ϩ) (Novagen) to express a thioredoxin (TRX) fusion (pRJ259 and pRJ258, respectively). Escherichia coli XL-1 blue and GM48 (Stratagene) were used for expressing GST fusions, and E. coli BL21 (DE3) (Novagen) was used for expressing TRX fusions. The expression of fusion proteins was induced by the addition of IPTG (isopropyl-␤-D-thiogalactopyranoside, 1 mM final concentration) to the culture. Bacterial pellets were resuspended in buffer ST (50 mM Tris-HCl [pH 8.0], 150 mM NaCl) with 100 g of lysozyme per ml and were sonicated briefly on ice (13) . Extracts were cleared by centrifugation at 12,000 rpm for 15 min in a Sorvall SS-34 rotor. Extracts containing equivalent amounts of GST-Snf4, GST-Snf1 regulatory domain, and GST proteins were incubated with glutathione-Sepharose 4B beads (Pharmacia) at 4ЊC for 1 h. After being washed, beads were split into several equal portions (each 100 g of bound protein) for subsequent binding experiments. Extracts (350 g) expressing TRX-ASC Sip2 , TRX-Sip2⌬ASC, or TRX proteins were added to the above beads and allowed to bind at 4ЊC for 2 h in buffer ST (500 l). After being extensively washed with cold ST (10 ml), beads were boiled in sodium dodecyl sulfate (SDS) sample buffer (2ϫ) and loaded onto an SDS-10% polyacrylamide gel. Bound proteins were detected by Western analysis with a polyclonal antibody against TRX (Santa Cruz Biotechnology) and enhanced chemiluminescence (ECL) with ECL reagents (Amersham).
Nickel affinity chromatography. Yeast cells were grown to mid-log phase. Cells were harvested by centrifugation, washed once with 15 ml of cold ST buffer, and frozen at Ϫ80ЊC. Alternatively, cells were harvested by quick filtration through a 0.8-m-pore-size filter (Micron Separations Inc.), washed once with 15 ml of cold ST buffer, and frozen immediately by immersion in dry ice-methanol at Ϫ80ЊC. Cells were broken by vortexing with glass beads in ST buffer with 2 mM phenylmethylsulfonyl fluoride. Protein extracts were clarified by centrifugation (2000 rpm, 10 min, Sorvall SS-34 rotor) at 4ЊC. Extract (500 g) was incubated with 150 l of Ni 2ϩ -nitrilotriacetic acid (NTA)-agarose beads (Qiagen) in 250 l of ST buffer with 1% Triton X-100, 25 mM imidazole, and 0.5 mg of ovalbumin (Calbiochem) per ml for 2 h at 4ЊC on a nutator. Beads were then pelleted by centrifugation (500 rpm, 5 seconds, 4ЊC, Eppendorf microcentrifuge), and the supernatant containing the unbound protein was removed. The beads were then washed 10 times with cold binding buffer (1 ml) . To analyze the bound proteins, protein was eluted from the beads in ST plus 0.2 M EDTA (100 l) or the beads were directly boiled in 2ϫ sample buffer. Proteins were separated by SDSpolyacrylamide gel electrophoresis and analyzed by immunoblotting. Antibodies were detected by ECL.
RESULTS
Snf4 protein is associated with Snf1 in cells grown in high and low levels of glucose. To examine the association of Snf1 and Snf4, we used nickel affinity chromatography to isolate Snf1, taking advantage of an intrinsic polyhistidine stretch (13 consecutive His) at the N terminus of Snf1. Extracts were first prepared from cells grown in high-concentration glucose (2%), and the Snf1 kinase complex was coordinated to Ni 2ϩ -NTAagarose beads. All of the Snf1 protein present in the extract was bound to the beads (Fig. 1A) . Binding was dependent on the presence of the polyhistidine stretch as the Snf1⌬H protein, which lacks these histidine residues (4), did not bind. We then prepared, in parallel, extracts from cells grown in either high-concentration glucose or galactose-glycerol-ethanol plus 0.05% glucose. The Snf1 protein was purified on the Ni 2ϩ -NTA-agarose resin, and the association of Snf4 with Snf1 was analyzed by immunoblotting with Snf4 antibody (11) . In both cases, all of the Snf4 protein in the extract was bound with Snf1 to the beads (Fig. 1B) . The results for controls with a snf1⌬ strain (lanes 7 to 9) indicated that Snf4 does not bind to the beads in the absence of Snf1. Therefore, Snf4 protein is associated with Snf1 in cells grown in both high and low levels of glucose.
This finding, together with previous evidence (6, 11, 28, 45) , supports the view that the glucose-regulated interaction between Snf1 and Snf4 in the two-hybrid system (23) reflects a conformational change in the kinase complex. A further implication is that in cells grown with a high glucose level another (24) , pGAD2F (7), pSH2-1 (18), pLexA(1-202)ϩPL (32), pGEX3X (Pharmacia), and pET-32a(ϩ) (Novagen).
protein (or proteins) in the Snf1 complex maintains the association of Snf4 with Snf1.
Association of Snf4 with Snf1 is impaired in a sip1⌬ sip2⌬ gal83⌬ triple mutant. The other known components of Snf1 complexes are Sip1, Sip2, and Gal83, which belong to a family of proteins whose members are thought to be alternate members of the kinase complex (10, 30, 44, 45) . Previous studies demonstrated the interaction of these proteins with Snf1 in glucose-grown cells (44, 45) . Thus, these three are candidates for proteins that could mediate the interaction between Snf1 and Snf4. To determine whether Sip1, Sip2, and Gal83 contribute to the association of Snf1 and Snf4 in complexes, we tested for the copurification of Snf4 with Snf1 from a sip1⌬ sip2⌬ gal83⌬ triple-deletion mutant using nickel affinity chromatography. In contrast to the results with the wild type, about half of the total Snf4 protein was in the unbound fraction, regardless of whether cells were grown in medium with a high level of glucose or in galactose-glycerol-ethanol plus 0.05% glucose (Fig. 1C) . Thus, the association of Snf4 with Snf1 is impaired in the triple mutant, indicating that Sip1, Sip2, and Gal83 play a role in maintaining the structure of Snf1 kinase complexes. These results do not distinguish whether this family is partially responsible for the integrity of most Snf1 complexes or rather plays an essential role in about half of the (heterogeneous) Snf1 complexes.
Sip1, Sip2, and Gal83 interact independently with both Snf1 and Snf4. Sip1, Sip2, and Gal83 could contribute to the association of Snf4 with Snf1 either by directly interacting with each of these proteins, thereby anchoring them in a complex, or by indirectly contributing to the structural integrity of the complex. To address the possibility that Sip1, Sip2, and Gal83 interact independently with both Snf1 and Snf4, we used the two-hybrid system. We first tested for the two-hybrid interaction of LexA-Sip1 432-863 , containing the C-terminal region that is homologous to Sip2 and Gal83, and LexA-Sip2 with Snf4-GAD ( Fig. 2A) . In each case, the interaction was readily detected in a wild-type host. Furthermore, the interaction was preserved in a snf1⌬ host, indicating that Sip1 and Sip2 interact with SNF4 independently of Snf1. Sip1 and Sip2 also interacted with GAD-Snf1 in a snf4⌬ mutant strain ( Fig. 2A) , consistent with previous coimmunoprecipitation results (45) .
LexA-Gal83 activates transcription on its own, so interactions of Gal83 were assayed with a GAD-Gal83 fusion (Fig.  2C) . GAD-Gal83 interacted with LexA-Snf1 and LexA 87 -Snf4 in wild-type and also in snf4⌬ and snf1⌬ mutant hosts, respectively. Therefore, Sip1, Sip2, and Gal83 are each capable of interacting independently with both Snf1 and Snf4.
C-terminal ASC domain of Sip2 interacts with Snf4. Previous studies showed that Sip1, Sip2, and Gal83 contain a conserved C-terminal sequence of about 80 residues, designated the ASC domain (Fig. 3B) , that mediates association with the Snf1 kinase complex in wild-type cells (45) . Association was detected both by two-hybrid interaction and coimmunoprecipitation. From these data, however, it was not clear whether the ASC domain interacts directly with Snf1, Snf4, or yet another component of the complex. To determine whether the ASC domain interacts with Snf1 or Snf4, we tested two-hybrid interactions in mutant hosts. LexA fusions to the ASC Sip1 and ASC Sip2 domains interacted with Snf4-GAD in both wild-type and snf1⌬ strains, and quantitative assays of ␤-galactosidase activity confirmed that interaction was strong in the snf1⌬ mutant ( Fig. 2A) . Moreover, deletion of the ASC domain from Sip2 (Sip2⌬ASC) abolished interaction with Snf4-GAD. Thus, the ASC domain is necessary and sufficient for Snf1-independent interaction with Snf4.
These findings suggested that the interaction detected between the ASC domain and Snf1 in wild-type cells (45) requires Snf4. Consistent with this model, interactions of LexA-ASC Sip1 and LexA-ASC Sip2 with GAD-Snf1 were abolished in a snf4⌬ mutant (Fig. 2A) . Control experiments confirmed that the loss of interaction cannot be attributed to the inability of the snf4⌬ strain to respond to glucose starvation, as the ASC domains interacted with the catalytic mutant GAD-Snf1-K84R in a snf1⌬ strain (data not shown). Further support for the idea that Snf4 mediates interaction of the ASC domain with Snf1 was provided by mapping the interacting regions of Snf1: the ASC Sip2 domain and Snf4 showed similar profiles of interaction with a panel of GAD-Snf1 fusions (23) (Fig. 4A) .
FIG. 1. Copurification of Snf4 with Snf1 on Ni
2ϩ -NTA affinity resin. Strains were MCY829 (wild type, WT), MCY2916 (snf1⌬), MCY2916 carrying pSNF1-⌬H, and MCY2728 (sip1⌬ sip2⌬ gal83⌬). pSNF1-⌬H is a CEN plasmid with the SNF1-⌬H allele, from which 12 adjacent His codons have been deleted (4). (A) Cells of the indicated genotype were grown to mid-log phase in YEP or SC medium containing 2% glucose, harvested by centrifugation, and used to prepare protein extracts. Proteins (500 g) were incubated with Ni 2ϩ -NTA-agarose beads, unbound protein (U) was removed, and one-fifth was analyzed. After being washed, beads were boiled in 2ϫ sample buffer, and one-fifth of the Ni 2ϩ -bound protein (N) was analyzed. Proteins were separated on an SDS-10% polyacrylamide gel and were analyzed by immunoblotting with Snf1 antiserum (5). Lanes 1, 4, and 6 show 100 g of total input protein (T). (B and C) Cells were grown in YEP medium containing either 2% glucose (Glu) or 2% galactoseglycerol-ethanol plus 0.05% glucose (Gal/Gly/ETOH) and were harvested by quick filtration. The binding assay was performed as described for panel A except that bound proteins were eluted from the beads and immunoblotting was performed with affinity-purified Snf1 and Snf4 antibodies (11, 45 
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To confirm that the interaction between Snf4 and the ASC domain is direct, we tested their interaction in vitro using bacterially expressed GST-Snf4 and TRX-ASC Sip2 , a fusion between TRX and the ASC Sip2 domain. GST-Snf4 and GST proteins were immobilized on glutathione-Sepharose 4B beads and allowed to bind to bacterial extracts containing TRX-ASC Sip2 or TRX proteins. After being extensively washed, bound proteins were analyzed by Western blotting with an antibody against TRX. Specific interaction was detected between GST-Snf4 and TRX-ASC Sip2 (Fig. 5A) .
A conserved region internal to Sip1, Sip2, and Gal83 interacts with Snf1. The preceding evidence shows that Sip1 and Sip2 interact with Snf4 in a Snf1-independent manner via the ASC domain. Evidence also indicates that Sip1, Sip2, and Gal83 interact with Snf1 in a Snf4-independent manner. Interactions were detected in the two-hybrid system in a snf4⌬ strain ( Fig. 2A and C) , and Sip1 and Sip2 coimmunoprecipitated with Snf1 from a snf4⌬ mutant extract (45) . This Snf4-independent mechanism does not require the ASC domain, as LexASip2⌬ASC also interacted with GAD-Snf1 in a snf4⌬ mutant (Fig. 2A) .
To define the Sip2 sequence that interacts with Snf1, we tested a panel of GAD fusions to partial Sip2 sequences for interaction with LexA-Snf1. Assays were carried out in a snf4⌬ strain to eliminate interaction mediated by Snf4. The Snf1-interacting region was mapped to residues 154 to 335 (Fig. 2B  and 3A ). An analysis of Gal83 further restricted the N terminus of the Snf1-interacting region, as codons 198 to 350 were sufficient (Fig. 2C) . For Sip1, the region C-terminal to residues 511 was sufficient for interaction with Snf1 in a snf4⌬ mutant, while a region C-terminal to codon 585 was not ( Fig. 3A; data not shown). We will refer to the Snf1-interacting region in Sip1, Sip2, and Gal83 as KIS, for kinase-interacting sequence.
The KIS region of Gal83 includes the site of the semidominant mutation GAL83-2000, which confers partially glucoseinsensitive GAL gene expression in mutants defective in inhibition of Gal4 by Gal80 (10, 27) . The relevant mutation appears to be a change of Gly-235 to Arg, so we will refer to the mutation as GAL83-G235R here. The G235 residue is conserved in Sip1 and Sip2 and also in the Kluyveromyces lactis homolog Fog1 (15) and in mammalian Sip2 homologs (38, 40) (Fig. 3A) . One possible model is that the mutant Gal83 protein competes better than the wild type with Sip1 and Sip2 for binding to Snf1 and thereby directs Snf1 more effectively to its targets in the galactose pathway, even allowing some phosphorylation in glucose. Another possibility is that the mutant Gal83 protein affects the regulation of Snf1 activity and that these kinase complexes are also directed by Gal83 to targets in the galactose pathway. To test the effect of this mutation on interaction with Snf1, we constructed a mutant GAD-Gal83-G235R fusion. Assays of interactions with LexA-Snf1 in a wild-type host, grown in medium containing glucose, showed that the mutation causes a very modest increase in ␤-galactosidase activity (Fig. 2C) . Similarly, for cells grown in galactoseglycerol-ethanol plus 0.05% glucose, ␤-galactosidase activity values were 364 U for GAD-Gal83 and 736 U for the mutant protein (averages for four transformants; standard error, Ͻ12%). It is possible that these increases reflect improved interaction with Snf1, especially as overexpression of these fusion proteins may drive their association in vivo and thereby minimize the observed differences.
Sip2 interacts with the C terminus of the Snf1 regulatory domain. To delineate the Snf1 sequence that interacts with Sip2, we tested a series of GAD-Snf1 fusions (23) for interaction with LexA-Sip2⌬ASC (Fig. 4A) . The extreme C terminus of Snf1 (residues 515 to 633) was necessary and sufficient for interaction in wild-type and snf4⌬ strains. This region is distinct from the binding site for Snf4 (23) . LexA-Sip2 was also tested against the panel of GAD-Snf1 sequences in both wildtype and snf4⌬ hosts, and as predicted, the results correspond to the sum of the interactions detected with Sip2⌬ASC and ASC Sip2 (Fig. 4A) .
To confirm that Snf1RD binds directly to Sip2⌬ASC, we assayed for in vitro binding of bacterially expressed GSTSnf1RD and TRX-Sip2⌬ASC fusions. Interaction was de-FIG. 2. Two-hybrid interactions of Sip1, Sip2, and Gal83 sequences with Snf4 and Snf1. Strains were CTY10-5d (wild type, WT) and MCY2916 (snf1⌬) or MCY2634 (snf4⌬) carrying a lexAop-lacZ reporter on pSH18-18. Proteins were expressed from the plasmids listed in Table 1 . Shaded bar, ASC domain. Interactions in filter lift assays are indicated by plus signs. (A) Values shown in parentheses are average ␤-galactosidase activities for two to six transformants ‫,ء(‬ one transformant). Standard errors were Ͻ26% with one exception (40% for LexA-Sip2 plus Snf4-GAD in the snf1⌬ mutant). LexA fusions did not interact with GAD or control GAD fusions. LexA 87 -Sip2⌬ASC plus GAD or Snf4-GAD gave a light blue color and low activity, so the interaction was scored as negative; in other experiments, GAD-Sip2⌬ASC did not interact with LexA 87 -Snf4 in the wild type. Immunoblotting confirmed that the ASC Sip1 and ASC Sip2 fusions were expressed in a snf4⌬ mutant and that deletion of the ASC domain from Sip2⌬ASC did not affect protein levels (43) . The data for interaction with GAD-Snf1 in the wild type is from reference 45. (B) In controls, GAD-ASC Sip2 interacted with LexA-Snf1 and LexA 87 -Snf4 in CTY10-5d. Dark bar, Snf1-interacting KIS region. (C) Values shown in parentheses are average ␤-galactosidase activities for four transformants grown in medium containing 4% glucose; GADGal83 plus LexA yielded 0.7 U. Standard errors were Ͻ8%. GAD-Gal83 4-417 was used to test interaction with LexA-Snf1 in the snf4⌬ strain. ND, not determined. tected between these fusion proteins; GST and TRX served as controls (Fig. 5B) .
A plant Snf1 homolog interacts with Sip2. Previously, we showed that the tobacco NPK5 kinase, a Snf1 functional homolog, interacts with the yeast Snf4 protein in a glucose-regulated manner (23) . The Sip2-interacting region of Snf1 is conserved in NPK5 (Fig. 4B) , raising the possibility that the ability to interact with the Sip1/Sip2/Gal83 family might also be conserved. To test this idea, we constructed a GAD-NPK5 fusion which complements the snf1⌬ mutation in yeast for growth on raffinose. GAD-NPK5 interacted with LexA-Sip2 in wild-type yeast cells (Fig. 6) . Furthermore, this interaction also occurred in a snf4⌬ mutant, indicating that it is not bridged by Snf4. Thus, interaction between the kinase and Sip2 is conserved from yeast to plants.
DISCUSSION
The Snf1 protein kinase and its activating subunit, Snf4, are complexed with members of a family of proteins comprising Sip1, Sip2, and Gal83. Here, we present evidence that the loss of these proteins impairs the association of Snf4 with Snf1 in cell extracts. We then show that each of these three proteins interacts directly with both Snf1 and Snf4 via two distinct conserved domains. The C-terminal ASC domains of Sip1, Sip2, and Gal83 bind to Snf4 independently of Snf1, and the internal KIS region interacts with Snf1 independently of Snf4. We also show that Sip2 interacts with the regulatory domain of Snf1. These interactions were mapped by using the two-hybrid system and were confirmed by in vitro binding studies. Quantitative assays of key two-hybrid results, together with previous coimmunoprecipitation studies (45) , showed that these interactions occur in cells grown in high levels of glucose. Together, these findings indicate that one of the functions of the Sip1/ Sip2/Gal83 family is to anchor Snf1 and Snf4 into a complex (Fig. 7) .
These findings offer a resolution of a puzzling discrepancy between two-hybrid and biochemical evidence. In the twohybrid system, the interaction between Snf1 and Snf4 is inhibited by glucose, whereas biochemical evidence indicates that Snf4 remains associated with Snf1 in glucose-grown cells. Previously, we proposed that other proteins could hold Snf1 and Snf4 together in a complex in medium containing glucose, despite their lack of direct interaction with one another (23) . Evidence that Sip1, Sip2, and Gal83 serve such a function supports the view that the glucose-regulated interaction between Snf1 and Snf4 in the two-hybrid system (23) reflects a conformational change in the kinase complex (Fig. 7) .
Genetic studies have addressed the role of Sip1, Sip2, and Gal83 in the Snf1 kinase pathway. Increased SIP1 and GAL83 gene dosage suppresses certain growth defects in snf4 mutants (44, 45) , and the GAL83-2000(G235R) allele relieves glucose repression of GAL genes in certain mutant backgrounds (10, 27) . In these experiments, the differential effects on SUC and GAL gene expression suggested that Sip1, Sip2, and Gal83 serve as adaptors that mediate interaction of the kinase with specific intracellular targets; the extended N-terminal sequence which is divergent between Sip1, Sip2, and Gal83 may play this role. In addition, Gal83 is required for Snf1 kinase activity in vitro; kinase activity is dramatically reduced in immune complex assays of gal83⌬ mutants, as is also the case for snf4⌬ mutants (45) . Nonetheless, the Sip1/Sip2/Gal83 family is not essential for many of the functions of the Snf1 kinase pathway in vivo, and a triple mutant lacking all three genes does not exhibit defects in carbon source utilization associated with a Snf Ϫ phenotype (10, 45) . If the Sip1/Sip2/Gal83 family contributes to the association of Snf4 with the Snf1 kinase in a complex, how can we account for the nearly normal phenotype of the sip1⌬ sip2⌬ gal83⌬ triple mutant? One simple explanation arises from the finding that in extracts from the triple mutant, half of the Snf4 protein still binds with Snf1 to nickel affinity beads. These results could indicate that Sip1, Sip2, and Gal83 are only partially responsible for maintaining the association of Snf4 with Snf1, with other unidentified proteins in the complex also contributing. Alternatively, the kinase complexes in the cell may be heterogeneous, and only half of the complexes may require Sip1, Sip2, and Gal83 for their integrity. However, in either case, the remaining intact Snf1 kinase complexes could suffice to confer a normal phenotype. Another possibility is that the constitutive association of Snf4 with Snf1 optimizes the regulatory response to glucose starvation but is not required for adequate function of the kinase pathway, at least with respect to the phenotypes tested. Even if Snf4 and Snf1 are not complexed, their association in response to glucose deprivation may not be the limiting factor in vivo. These two possibilities are not mutually exclusive.
The composition of the Snf1-Snf4 complexes detected in the absence of Sip1, Sip2, and Gal83 is not clear. Other proteins may be functionally redundant with Sip1, Sip2, and Gal83. The Sip1/Sip2/Gal83 family does not appear to include other members; no other close sequence homologs are found in the yeast genome, and disruption of the more distant homolog YHR146 in a sip1 sip2 gal83 triple mutant did not produce a Snf Ϫ phenotype (26) . However, nonhomologous proteins may serve a redundant function. A purified Snf1-Snf4 complex did not contain any other proteins in stoichiometric amounts (28, 38) ; however, this complex may have been purified from glucosedeprived cells. Under conditions of glucose limitation, Snf1 and Snf4 can interact directly, without assistance from other proteins (23) .
Studies of Snf1-related kinase complexes in other organisms lend further support to the idea that the Sip1/Sip2/Gal83 family members are important components of the kinase complex. First, genetic evidence indicates a functional requirement in the yeast K. lactis. Both Fog1, a Sip1/Sip2/Gal83 homolog (Fig.  3) , and Fog2, a Snf1 homolog, are required for expression of glucose-repressed genes, and fog1 and fog2 mutants have similar phenotypes (15) . Second, the Sip2-interacting region in Snf1 is conserved in the Snf1 kinase family (Fig. 4B) , and we show here that the tobacco homolog NPK5 interacts with Sip2. Finally, purified mammalian AMPK contains a catalytic subunit homologous to Snf1 (AMPK␣) and homologs of Snf4 (AMPK␥) and Sip2 (AMPK␤) (38, 40) . AMPK␤ contains regions corresponding to the KIS and ASC domains (Fig. 3) . Experiments with in vitro-translated proteins indicated that AMPK␤ interacts separately with AMPK␣ and AMPK␥ and also mediates formation of a ternary complex (40) .
Thus, Sip1, Sip2, and Gal83 represent a conserved family of proteins that may play dual roles in the function of the Snf1 kinase complex. Here, we present evidence that these proteins play a structural role in the complex, anchoring the Snf4 activating subunit together with the Snf1 kinase. This function employs two distinct domains that are conserved in each of the Sip1, Sip2, and Gal83 proteins. Previous genetic evidence suggested that these proteins have differing functions in the Snf1 pathway (10, 44, 45) and may serve as adaptors that mediate the interaction of the kinase with different substrate proteins or as targeting proteins that direct the kinase to different intracellular locations (45) . Further study will be required to determine whether the divergent N-terminal sequences of Sip1, Sip2, and Gal83 play such a role.
